GZMB and lung carcinoma: discovered that the granzyme B inhibitor PI-9 was highly expressed in lung cancer cell lines, and an increase in PI-9 expression was also observed in primary cancer cells, inhibiting granzyme B-mediated cellular toxicity and enabling immune escape (97).